DD202031A5 - 2,9-dioxatricyclo(4,3,1,0 hoch 3, hoch 7) decane - Google Patents

2,9-dioxatricyclo(4,3,1,0 hoch 3, hoch 7) decane Download PDF

Info

Publication number
DD202031A5
DD202031A5 DD81231625A DD23162581A DD202031A5 DD 202031 A5 DD202031 A5 DD 202031A5 DD 81231625 A DD81231625 A DD 81231625A DD 23162581 A DD23162581 A DD 23162581A DD 202031 A5 DD202031 A5 DD 202031A5
Authority
DD
German Democratic Republic
Prior art keywords
group
compound
acetoxy
hydroxy
item
Prior art date
Application number
DD81231625A
Other languages
German (de)
English (en)
Inventor
Thies
David
Original Assignee
Kali Chemie Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kali Chemie Pharma Gmbh filed Critical Kali Chemie Pharma Gmbh
Publication of DD202031A5 publication Critical patent/DD202031A5/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/94—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems condensed with rings other than six-membered or with ring systems containing such rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Photoreceptors In Electrophotography (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Steroid Compounds (AREA)
DD81231625A 1980-07-14 1981-07-09 2,9-dioxatricyclo(4,3,1,0 hoch 3, hoch 7) decane DD202031A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19803026579 DE3026579A1 (de) 1980-07-14 1980-07-14 2,9-dioxatricyclo (4,3,1,o(pfeil hoch)3,7(pfeil hoch)) decane

Publications (1)

Publication Number Publication Date
DD202031A5 true DD202031A5 (de) 1983-08-24

Family

ID=6107116

Family Applications (1)

Application Number Title Priority Date Filing Date
DD81231625A DD202031A5 (de) 1980-07-14 1981-07-09 2,9-dioxatricyclo(4,3,1,0 hoch 3, hoch 7) decane

Country Status (19)

Country Link
US (1) US4391819A (el)
EP (1) EP0043967B1 (el)
JP (1) JPS57501030A (el)
AT (1) ATE2791T1 (el)
AU (1) AU542720B2 (el)
CA (1) CA1167459A (el)
DD (1) DD202031A5 (el)
DE (2) DE3026579A1 (el)
DK (1) DK109482A (el)
ES (1) ES503895A0 (el)
GR (1) GR75723B (el)
HU (1) HU183655B (el)
IL (1) IL63176A (el)
NO (1) NO151466C (el)
NZ (1) NZ197509A (el)
PH (1) PH16115A (el)
PT (1) PT73303B (el)
WO (1) WO1982000292A1 (el)
ZA (1) ZA814585B (el)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3327811A1 (de) * 1983-08-02 1985-02-21 Kali-Chemie Pharma Gmbh, 3000 Hannover Neue valepotriathydrinhaltige arzneimittel
US5506268A (en) * 1993-06-11 1996-04-09 Nps Pharmaceuticals, Inc. Use of isovaleramide as a mild anxiolytic and sedative agent
DE69714230T2 (de) * 1996-03-06 2003-03-27 Tsumura & Co., Tokio/Tokyo Neue iridoidderivate und neovaskularisations-inhibitoren die diese als aktviven inhaltstoff enthalten
US6127415A (en) * 1996-07-08 2000-10-03 Galderma Research & Development, S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents
US6462064B1 (en) 1996-07-08 2002-10-08 Galderma Research & Development S.N.C. Apoptosis inducing adamantyl derivatives and their usage as anti-cancer agents, especially for cervical cancers and dysplasias
US6225478B1 (en) 1997-03-05 2001-05-01 Tsumura & Co. Iridoid derivatives and neovascularization inhibitors containing the same as active ingredient
US10329759B2 (en) 2012-09-17 2019-06-25 Steelcase Inc. Floor-to-ceiling partition wall assembly
WO2015148951A1 (en) 2014-03-28 2015-10-01 Steelcase Inc. Transparent panel system for partitions

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3812154A (en) * 1969-12-08 1974-05-21 Kali Chemie Ag Dioxatricyclodecanes
BE795194A (fr) * 1972-02-10 1973-08-09 Ciba Geigy Nouveau dioxatricyclodecanol, ses esters et leurs procedes de preparation
DE2607106C2 (de) * 1976-02-21 1986-01-16 Kali-Chemie Pharma Gmbh, 3000 Hannover 2,9-Dioxatricyclo[4,3,1,0↑3↑↑,↑↑7↑]decane und Verfahren zu deren Herstellung

Also Published As

Publication number Publication date
PT73303B (en) 1982-07-30
PH16115A (en) 1983-06-30
NO820820L (no) 1982-03-12
NO151466C (no) 1985-04-17
US4391819A (en) 1983-07-05
WO1982000292A1 (en) 1982-02-04
EP0043967B1 (de) 1983-03-16
AU542720B2 (en) 1985-03-07
HU183655B (en) 1984-05-28
DK109482A (da) 1982-03-12
ES8205806A1 (es) 1982-07-01
ATE2791T1 (de) 1983-04-15
GR75723B (el) 1984-08-02
ES503895A0 (es) 1982-07-01
DE3026579A1 (de) 1982-02-11
PT73303A (en) 1981-08-01
DE3160116D1 (de) 1983-04-21
NZ197509A (en) 1983-09-30
IL63176A (en) 1984-05-31
EP0043967A1 (de) 1982-01-20
NO151466B (no) 1985-01-02
AU7281481A (en) 1982-01-21
CA1167459A (en) 1984-05-15
ZA814585B (en) 1982-07-28
JPS57501030A (el) 1982-06-10
IL63176A0 (en) 1981-09-13

Similar Documents

Publication Publication Date Title
DE2729859C2 (de) Verfahren zur Herstellung von 6a,10a-cis- oder -trans-1-Hydroxy-3-alkyl-6,6-dimethyl-6,6a,7,8,10,10a-hexahydro-9H-dibenzo[b,d]pyran-9-onen
DE1443591A1 (de) Glucofuranoside und Verfahren zu ihrer Herstellung
DE2030402C3 (el)
DE69600292T2 (de) Cyclodextrin Derivate
EP0043967B1 (de) 2,9-Dioxatricyclo(4,3,1,0(3,7))decane
DE2504045C3 (de) 16,17 Dihydro-apovincaminsäure-2hydroxypropylester, deren Salze, Verfahren zu ihrer Herstellung und Arzneimittel
DE1917874A1 (de) Verfahren zur Herstellung von Adriamycin und Adriamycinon
DE1493976C3 (de) Substituierte Flavandenvate sowie Verfahren zu ihrer Herstellung
DE1695375C3 (de) 25-Desacetyl-rifamycin-SV-derivate u. Verfahren zu ihrer Herstellung
DE2129507C3 (de) Verfahren zur Herstellung von 8-Alkoxy-3halogenmethyl-4-acetoxy- 10-methylen-2,9dioxatricyclo(43,l,03 7 )decanen
DE69400352T2 (de) 3- oder 4-Glykosyloxybenzopyranderivat und dieses enthaltende antiallergisches Mittel
DE1543769C3 (de) 7-Methoxy-flavanderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
DE2502919C2 (de) Cyclopentan-Derivate, Verfahren zu ihrer Herstellung, sowie diese enthaltende pharmazeutische Zusammensetzungen
DE3851938T2 (de) Polyaromatische Ester von makroliden Antibiotika und linkosamiden Antibiotika, Verfahren zu ihrer Herstellung und diese enthaltenden pharmazeutischen und kosmetischen Zusammensetzungen.
DE3200809C2 (de) 4'-Desoxy-3'-epi-daunorubicin und -doxorubicin, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
CH628639A5 (en) Process for the preparation of furanose derivatives
DD210034A5 (de) Verfahren zur herstellung von pirbuterol
DE3851937T2 (de) Nicht gesättigte cycloaliphatische Ester von makroliden Antibiotika und linkosamiden Antibiotika, Verfahren zu ihrer Herstellung und die sie enthaltenden pharmazeutischen und kosmetischen Zusammensetzungen.
DE2700341A1 (de) Oxo-c-ring-benzopyrane
DE2547205A1 (de) 2,9-dioxatricyclo eckige klammer auf 4,3,1,0 hoch 3,7 eckige klammer zu decane und verfahren sowie zwischenprodukte zu deren herstellung
DE2150270C3 (de) Pregnansäure-Derivate und Verfahren zu ihrer Herstellung
DE2832857A1 (de) Verfahren zur herstellung wasserloeslicher hydroxy-flavonaether
CH616691A5 (en) Process for the preparation of steroid compounds and their use.
DE1913491B2 (de) Verfahren zur Herstellung von 4,5-Epoxy-14-beta-hydroxy-20,22-bufadienoliden sowie 4,5 -Epoxy-14 beta-hydroxy-20,22-bufadienolW-Verbindungen
DE2516623A1 (de) 4-substituierte chromen-2-carbonsaeurederivate, ihre verwendung sowie verfahren zur herstellung derselben und von chrom-4-on-2-carbonsaeurederivaten